HEADER IMMUNE SYSTEM/INHIBITOR 04-MAR-10 3M17 TITLE CRYSTAL STRUCTURE OF HUMAN FCRN WITH A MONOMERIC PEPTIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: IGG RECEPTOR FCRN LARGE SUBUNIT P51; COMPND 3 CHAIN: A, C, E, G; COMPND 4 FRAGMENT: UNP RESIDUES 24-290; COMPND 5 SYNONYM: FCRN, NEONATAL FC RECEPTOR, IGG FC FRAGMENT RECEPTOR COMPND 6 TRANSPORTER ALPHA CHAIN; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 10 CHAIN: B, D, F, H; COMPND 11 FRAGMENT: UNP RESIDUES 21-119; COMPND 12 SYNONYM: BETA-2-MICROGLOBULIN FORM PI 5.3; COMPND 13 ENGINEERED: YES; COMPND 14 MOL_ID: 3; COMPND 15 MOLECULE: MONOMERIC PEPTIDE INHIBITOR; COMPND 16 CHAIN: I, J, K, L; COMPND 17 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FCGRT, FCRN; SOURCE 6 EXPRESSION_SYSTEM: CRICETINAE; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HAMSTERS; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 10026; SOURCE 9 EXPRESSION_SYSTEM_CELL: CHOK1SV CELLS; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: B2M, CDABP0092, HDCMA22P; SOURCE 15 EXPRESSION_SYSTEM: CRICETINAE; SOURCE 16 EXPRESSION_SYSTEM_COMMON: HAMSTERS; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 10026; SOURCE 18 EXPRESSION_SYSTEM_CELL: CHOK1SV CELLS; SOURCE 19 MOL_ID: 3; SOURCE 20 SYNTHETIC: YES; SOURCE 21 OTHER_DETAILS: ARTIFICIAL PEPTIDE KEYWDS IMMUNOGLOBULIN BINDING PROTEIN, CELL MEMBRANE, DISULFIDE BOND, KEYWDS 2 GLYCOPROTEIN, IGG-BINDING PROTEIN, IMMUNOGLOBULIN DOMAIN, MEMBRANE, KEYWDS 3 RECEPTOR, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, KEYWDS 4 GLYCATION, IMMUNE RESPONSE, MHC I, PYRROLIDONE CARBOXYLIC ACID, KEYWDS 5 SECRETED, IMMUNE SYSTEM-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.R.MEZO,V.SRIDHAR,J.BADGER,P.SAKORAFAS,V.NIENABER REVDAT 6 22-NOV-23 3M17 1 REMARK REVDAT 5 06-SEP-23 3M17 1 REMARK REVDAT 4 04-MAY-22 3M17 1 HETSYN LINK REVDAT 3 24-AUG-11 3M17 1 HEADER LINK VERSN REVDAT 2 15-SEP-10 3M17 1 JRNL REVDAT 1 16-JUN-10 3M17 0 JRNL AUTH A.R.MEZO,V.SRIDHAR,J.BADGER,P.SAKORAFAS,V.NIENABER JRNL TITL X-RAY CRYSTAL STRUCTURES OF MONOMERIC AND DIMERIC PEPTIDE JRNL TITL 2 INHIBITORS IN COMPLEX WITH THE HUMAN NEONATAL FC RECEPTOR, JRNL TITL 3 FCRN. JRNL REF J.BIOL.CHEM. V. 285 27694 2010 JRNL REFN ISSN 0021-9258 JRNL PMID 20592032 JRNL DOI 10.1074/JBC.M110.120667 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.10 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 48725 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.264 REMARK 3 R VALUE (WORKING SET) : 0.261 REMARK 3 FREE R VALUE : 0.325 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2606 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.67 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3492 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.3590 REMARK 3 BIN FREE R VALUE SET COUNT : 178 REMARK 3 BIN FREE R VALUE : 0.3920 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 11398 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 183 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.11 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.02000 REMARK 3 B22 (A**2) : -0.58000 REMARK 3 B33 (A**2) : 0.56000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 1.510 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.420 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.320 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 15.110 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.894 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.827 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 11766 ; 0.006 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 16067 ; 0.962 ; 1.940 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1472 ; 5.177 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 515 ;35.761 ;23.590 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1572 ;17.564 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 54 ;17.337 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1686 ; 0.066 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 9282 ; 0.002 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 4981 ; 0.175 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 7827 ; 0.296 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 468 ; 0.125 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 127 ; 0.176 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 14 ; 0.110 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3M17 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-MAR-10. REMARK 100 THE DEPOSITION ID IS D_1000057978. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-SEP-07 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 4.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 4.2.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51434 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 41.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -4.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1EXU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2UL PROTEIN:PEPTIDE WITH 2UL SOLUTION REMARK 280 OF 100MM SODIUM PHOSPHATE/CITRIC ACID, 20% PEG 3350, 8% ETHANOL, REMARK 280 PH 4.2, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 124.16500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 124.16500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 57.16000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 59.15000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 57.16000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 59.15000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 124.16500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 57.16000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 59.15000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 124.16500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 57.16000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 59.15000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 7 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 8 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 9 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 10 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: J REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 11 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: K REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 12 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE MONOMERIC PEPTIDE INHIBITOR IS PEPTIDE-LIKE, A MEMBER OF REMARK 400 INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: MONOMERIC PEPTIDE INHIBITOR REMARK 400 CHAIN: I, J, K, L REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 1 REMARK 465 GLU A 2 REMARK 465 SER A 3 REMARK 465 HIS A 4 REMARK 465 ALA C 1 REMARK 465 GLU C 2 REMARK 465 SER C 3 REMARK 465 HIS C 4 REMARK 465 ALA E 1 REMARK 465 GLU E 2 REMARK 465 SER E 3 REMARK 465 HIS E 4 REMARK 465 ALA G 1 REMARK 465 GLU G 2 REMARK 465 SER G 3 REMARK 465 HIS G 4 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 5 CG CD1 CD2 REMARK 470 GLU A 46 CG CD OE1 OE2 REMARK 470 VAL A 57 CG1 CG2 REMARK 470 SER A 58 OG REMARK 470 LYS A 63 CD CE NZ REMARK 470 LYS A 73 CD CE NZ REMARK 470 LYS A 85 CG CD CE NZ REMARK 470 ASN A 102 CG OD1 ND2 REMARK 470 LYS A 123 CG CD CE NZ REMARK 470 GLN A 143 CG CD OE1 NE2 REMARK 470 LYS A 146 CD CE NZ REMARK 470 LEU A 152 CG CD1 CD2 REMARK 470 PHE A 157 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG A 164 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 177 CE NZ REMARK 470 LYS A 185 CG CD CE NZ REMARK 470 ARG A 187 CG CD NE CZ NH1 NH2 REMARK 470 SER A 189 OG REMARK 470 SER A 190 OG REMARK 470 PHE A 193 CG CD1 CD2 CE1 CE2 CZ REMARK 470 SER A 194 OG REMARK 470 GLN A 209 CD OE1 NE2 REMARK 470 ARG A 211 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 214 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 215 CG OD1 ND2 REMARK 470 LEU A 217 CG CD1 CD2 REMARK 470 GLN A 223 CG CD OE1 NE2 REMARK 470 LYS A 243 CG CD CE NZ REMARK 470 HIS A 249 CG ND1 CD2 CE1 NE2 REMARK 470 GLN A 255 CG CD OE1 NE2 REMARK 470 LEU A 267 CG CD1 CD2 REMARK 470 LYS B 48 CG CD CE NZ REMARK 470 LYS B 58 CD CE NZ REMARK 470 LYS B 75 CG CD CE NZ REMARK 470 GLU B 77 CG CD OE1 OE2 REMARK 470 LYS B 91 CD CE NZ REMARK 470 LYS B 94 CD CE NZ REMARK 470 LEU C 5 CD1 CD2 REMARK 470 GLU C 46 CG CD OE1 OE2 REMARK 470 VAL C 57 CG1 CG2 REMARK 470 SER C 58 OG REMARK 470 TRP C 59 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP C 59 CZ3 CH2 REMARK 470 LYS C 63 CD CE NZ REMARK 470 LYS C 73 CD CE NZ REMARK 470 LYS C 80 CD CE NZ REMARK 470 LYS C 85 CG CD CE NZ REMARK 470 ASP C 101 CG OD1 OD2 REMARK 470 ASN C 102 CG OD1 ND2 REMARK 470 LYS C 123 CG CD CE NZ REMARK 470 GLN C 139 CG CD OE1 NE2 REMARK 470 GLN C 143 CG CD OE1 NE2 REMARK 470 LYS C 146 CD CE NZ REMARK 470 PHE C 157 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG C 164 CG CD NE CZ NH1 NH2 REMARK 470 GLU C 168 CG CD OE1 OE2 REMARK 470 LYS C 177 CE NZ REMARK 470 LYS C 185 CG CD CE NZ REMARK 470 ARG C 187 CG CD NE CZ NH1 NH2 REMARK 470 SER C 189 OG REMARK 470 SER C 190 OG REMARK 470 PHE C 193 CG CD1 CD2 CE1 CE2 CZ REMARK 470 SER C 194 OG REMARK 470 GLN C 209 CD OE1 NE2 REMARK 470 ARG C 211 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 214 CG CD NE CZ NH1 NH2 REMARK 470 ASN C 215 CG OD1 ND2 REMARK 470 LEU C 217 CG CD1 CD2 REMARK 470 GLN C 223 CG CD OE1 NE2 REMARK 470 LYS C 243 CG CD CE NZ REMARK 470 HIS C 248 CG ND1 CD2 CE1 NE2 REMARK 470 GLN C 255 CG CD OE1 NE2 REMARK 470 GLN C 261 CG CD OE1 NE2 REMARK 470 LEU C 267 CG CD1 CD2 REMARK 470 GLU D 47 CG CD OE1 OE2 REMARK 470 LYS D 48 CG CD CE NZ REMARK 470 LYS D 58 CD CE NZ REMARK 470 LYS D 75 CG CD CE NZ REMARK 470 GLU D 77 CG CD OE1 OE2 REMARK 470 LYS D 91 CD CE NZ REMARK 470 LYS D 94 CD CE NZ REMARK 470 LEU E 5 CD1 CD2 REMARK 470 ARG E 42 NE CZ NH1 NH2 REMARK 470 VAL E 57 CG1 CG2 REMARK 470 SER E 58 OG REMARK 470 TRP E 59 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP E 59 CZ3 CH2 REMARK 470 LYS E 63 CD CE NZ REMARK 470 LYS E 73 CD CE NZ REMARK 470 LYS E 80 CD CE NZ REMARK 470 LYS E 85 CG CD CE NZ REMARK 470 ASP E 101 CG OD1 OD2 REMARK 470 ASN E 102 CG OD1 ND2 REMARK 470 THR E 103 OG1 CG2 REMARK 470 LYS E 123 CG CD CE NZ REMARK 470 GLN E 139 CG CD OE1 NE2 REMARK 470 GLN E 143 CG CD OE1 NE2 REMARK 470 LYS E 146 CD CE NZ REMARK 470 PHE E 157 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU E 168 CG CD OE1 OE2 REMARK 470 LYS E 177 CE NZ REMARK 470 LYS E 185 CG CD CE NZ REMARK 470 ARG E 187 CG CD NE CZ NH1 NH2 REMARK 470 SER E 189 OG REMARK 470 SER E 190 OG REMARK 470 PHE E 193 CG CD1 CD2 CE1 CE2 CZ REMARK 470 SER E 194 OG REMARK 470 GLN E 209 CG CD OE1 NE2 REMARK 470 ARG E 211 CG CD NE CZ NH1 NH2 REMARK 470 ARG E 214 CG CD NE CZ NH1 NH2 REMARK 470 ASN E 215 CG OD1 ND2 REMARK 470 LEU E 217 CG CD1 CD2 REMARK 470 GLN E 223 CG CD OE1 NE2 REMARK 470 LYS E 243 CG CD CE NZ REMARK 470 SER E 244 OG REMARK 470 HIS E 249 CG ND1 CD2 CE1 NE2 REMARK 470 GLN E 255 CG CD OE1 NE2 REMARK 470 GLN E 261 CG CD OE1 NE2 REMARK 470 ARG E 264 CG CD NE CZ NH1 NH2 REMARK 470 LEU E 267 CG CD1 CD2 REMARK 470 GLU F 47 CG CD OE1 OE2 REMARK 470 LYS F 48 CG CD CE NZ REMARK 470 LYS F 58 CG CD CE NZ REMARK 470 LYS F 75 CG CD CE NZ REMARK 470 LYS F 91 CD CE NZ REMARK 470 LYS F 94 CD CE NZ REMARK 470 LEU G 5 CD1 CD2 REMARK 470 ARG G 42 NE CZ NH1 NH2 REMARK 470 VAL G 57 CG1 CG2 REMARK 470 SER G 58 OG REMARK 470 LYS G 63 CD CE NZ REMARK 470 LYS G 73 CD CE NZ REMARK 470 LYS G 85 CG CD CE NZ REMARK 470 ASP G 101 CG OD1 OD2 REMARK 470 ASN G 102 CG OD1 ND2 REMARK 470 LEU G 122 CG CD1 CD2 REMARK 470 LYS G 123 CG CD CE NZ REMARK 470 GLN G 124 CG CD OE1 NE2 REMARK 470 GLN G 139 CG CD OE1 NE2 REMARK 470 GLN G 143 CG CD OE1 NE2 REMARK 470 LYS G 146 CG CD CE NZ REMARK 470 ARG G 164 CG CD NE CZ NH1 NH2 REMARK 470 LEU G 167 CG CD1 CD2 REMARK 470 GLU G 168 CG CD OE1 OE2 REMARK 470 LYS G 177 CE NZ REMARK 470 LYS G 185 CG CD CE NZ REMARK 470 ARG G 187 CG CD NE CZ NH1 NH2 REMARK 470 SER G 189 OG REMARK 470 SER G 190 OG REMARK 470 PHE G 193 CG CD1 CD2 CE1 CE2 CZ REMARK 470 SER G 194 OG REMARK 470 VAL G 195 CG1 CG2 REMARK 470 GLN G 209 CG CD OE1 NE2 REMARK 470 ARG G 214 CG CD NE CZ NH1 NH2 REMARK 470 ASN G 215 CG OD1 ND2 REMARK 470 LEU G 217 CG CD1 CD2 REMARK 470 GLN G 223 CG CD OE1 NE2 REMARK 470 PHE G 226 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS G 243 CG CD CE NZ REMARK 470 HIS G 249 CG ND1 CD2 CE1 NE2 REMARK 470 GLN G 255 CG CD OE1 NE2 REMARK 470 GLN G 261 CG CD OE1 NE2 REMARK 470 ARG G 264 CG CD NE CZ NH1 NH2 REMARK 470 LEU G 267 CG CD1 CD2 REMARK 470 GLU H 16 CG CD OE1 OE2 REMARK 470 GLU H 44 CG CD OE1 OE2 REMARK 470 GLU H 47 CG CD OE1 OE2 REMARK 470 LYS H 48 CG CD CE NZ REMARK 470 LYS H 58 CG CD CE NZ REMARK 470 THR H 73 OG1 CG2 REMARK 470 GLU H 74 CG CD OE1 OE2 REMARK 470 LYS H 75 CG CD CE NZ REMARK 470 GLU H 77 CG CD OE1 OE2 REMARK 470 LYS H 91 CD CE NZ REMARK 470 LYS H 94 CD CE NZ REMARK 470 ASP H 98 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PHE I 2 O - C - N ANGL. DEV. = -16.3 DEGREES REMARK 500 LE1 I 3 C - N - CA ANGL. DEV. = 15.8 DEGREES REMARK 500 CYS I 13 O - C - N ANGL. DEV. = -11.4 DEGREES REMARK 500 PHE K 2 CA - C - N ANGL. DEV. = 15.1 DEGREES REMARK 500 PHE K 2 O - C - N ANGL. DEV. = -16.7 DEGREES REMARK 500 LE1 K 3 C - N - CA ANGL. DEV. = 19.9 DEGREES REMARK 500 CYS K 13 O - C - N ANGL. DEV. = -10.1 DEGREES REMARK 500 LE1 L 3 O - C - N ANGL. DEV. = 11.3 DEGREES REMARK 500 CYS L 13 O - C - N ANGL. DEV. = -10.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 58 -32.27 77.17 REMARK 500 ASN A 102 -37.97 70.23 REMARK 500 PHE A 117 -22.20 -145.20 REMARK 500 LYS A 146 -14.53 69.32 REMARK 500 PHE A 157 -69.36 -103.94 REMARK 500 TRP A 176 114.78 -36.93 REMARK 500 SER A 189 -120.69 -83.82 REMARK 500 PRO A 191 130.98 -39.55 REMARK 500 SER A 202 77.58 51.42 REMARK 500 GLU A 207 109.39 -55.69 REMARK 500 HIS B 31 135.44 -171.10 REMARK 500 LEU B 54 109.65 -54.08 REMARK 500 ASP B 98 63.59 74.96 REMARK 500 PRO C 32 20.38 -79.97 REMARK 500 SER C 58 -64.97 60.34 REMARK 500 PRO C 100 -72.85 -35.81 REMARK 500 PHE C 117 -19.89 -149.81 REMARK 500 LYS C 146 -21.29 80.61 REMARK 500 TRP C 176 109.19 -51.73 REMARK 500 SER C 189 -111.53 -111.62 REMARK 500 SER C 202 75.00 46.75 REMARK 500 ASN C 215 16.48 54.86 REMARK 500 TRP D 60 -0.94 79.18 REMARK 500 VAL E 57 34.82 -88.91 REMARK 500 SER E 58 -0.68 54.77 REMARK 500 ALA E 108 85.11 -150.12 REMARK 500 PHE E 117 -13.58 -147.10 REMARK 500 GLN E 124 18.50 -147.41 REMARK 500 PHE E 157 -60.06 -105.15 REMARK 500 SER E 189 -128.72 -84.66 REMARK 500 PRO E 191 124.55 -39.89 REMARK 500 SER E 202 74.80 46.69 REMARK 500 ASN E 215 -34.50 57.18 REMARK 500 ASP E 246 70.98 -102.25 REMARK 500 PRO F 32 -168.60 -79.27 REMARK 500 TRP F 60 -8.43 80.22 REMARK 500 ARG F 97 -177.24 -69.05 REMARK 500 ASP F 98 4.94 51.73 REMARK 500 SER G 58 -38.63 73.08 REMARK 500 PRO G 100 -71.16 -38.08 REMARK 500 ASP G 101 40.43 -92.88 REMARK 500 PHE G 117 -12.44 -146.45 REMARK 500 PRO G 191 107.74 -56.28 REMARK 500 SER G 202 70.84 47.83 REMARK 500 ASN G 215 60.03 39.87 REMARK 500 ASP G 225 125.34 -171.21 REMARK 500 ASP H 98 70.73 65.32 REMARK 500 LE1 I 3 116.96 -163.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 PHE I 2 -14.80 REMARK 500 PHE J 2 12.43 REMARK 500 LE1 J 3 12.29 REMARK 500 LE1 K 3 11.07 REMARK 500 PHE L 2 13.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3M1B RELATED DB: PDB DBREF 3M17 A 1 267 UNP P55899 FCGRN_HUMAN 24 290 DBREF 3M17 B 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 3M17 C 1 267 UNP P55899 FCGRN_HUMAN 24 290 DBREF 3M17 D 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 3M17 E 1 267 UNP P55899 FCGRN_HUMAN 24 290 DBREF 3M17 F 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 3M17 G 1 267 UNP P55899 FCGRN_HUMAN 24 290 DBREF 3M17 H 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 3M17 I 0 14 PDB 3M17 3M17 0 14 DBREF 3M17 J 0 14 PDB 3M17 3M17 0 14 DBREF 3M17 K 0 14 PDB 3M17 3M17 0 14 DBREF 3M17 L 0 14 PDB 3M17 3M17 0 14 SEQRES 1 A 267 ALA GLU SER HIS LEU SER LEU LEU TYR HIS LEU THR ALA SEQRES 2 A 267 VAL SER SER PRO ALA PRO GLY THR PRO ALA PHE TRP VAL SEQRES 3 A 267 SER GLY TRP LEU GLY PRO GLN GLN TYR LEU SER TYR ASN SEQRES 4 A 267 SER LEU ARG GLY GLU ALA GLU PRO CYS GLY ALA TRP VAL SEQRES 5 A 267 TRP GLU ASN GLN VAL SER TRP TYR TRP GLU LYS GLU THR SEQRES 6 A 267 THR ASP LEU ARG ILE LYS GLU LYS LEU PHE LEU GLU ALA SEQRES 7 A 267 PHE LYS ALA LEU GLY GLY LYS GLY PRO TYR THR LEU GLN SEQRES 8 A 267 GLY LEU LEU GLY CYS GLU LEU GLY PRO ASP ASN THR SER SEQRES 9 A 267 VAL PRO THR ALA LYS PHE ALA LEU ASN GLY GLU GLU PHE SEQRES 10 A 267 MET ASN PHE ASP LEU LYS GLN GLY THR TRP GLY GLY ASP SEQRES 11 A 267 TRP PRO GLU ALA LEU ALA ILE SER GLN ARG TRP GLN GLN SEQRES 12 A 267 GLN ASP LYS ALA ALA ASN LYS GLU LEU THR PHE LEU LEU SEQRES 13 A 267 PHE SER CYS PRO HIS ARG LEU ARG GLU HIS LEU GLU ARG SEQRES 14 A 267 GLY ARG GLY ASN LEU GLU TRP LYS GLU PRO PRO SER MET SEQRES 15 A 267 ARG LEU LYS ALA ARG PRO SER SER PRO GLY PHE SER VAL SEQRES 16 A 267 LEU THR CYS SER ALA PHE SER PHE TYR PRO PRO GLU LEU SEQRES 17 A 267 GLN LEU ARG PHE LEU ARG ASN GLY LEU ALA ALA GLY THR SEQRES 18 A 267 GLY GLN GLY ASP PHE GLY PRO ASN SER ASP GLY SER PHE SEQRES 19 A 267 HIS ALA SER SER SER LEU THR VAL LYS SER GLY ASP GLU SEQRES 20 A 267 HIS HIS TYR CYS CYS ILE VAL GLN HIS ALA GLY LEU ALA SEQRES 21 A 267 GLN PRO LEU ARG VAL GLU LEU SEQRES 1 B 99 ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG HIS SEQRES 2 B 99 PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS TYR SEQRES 3 B 99 VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP LEU SEQRES 4 B 99 LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SER SEQRES 5 B 99 ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU LEU SEQRES 6 B 99 TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU TYR SEQRES 7 B 99 ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO LYS SEQRES 8 B 99 ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 C 267 ALA GLU SER HIS LEU SER LEU LEU TYR HIS LEU THR ALA SEQRES 2 C 267 VAL SER SER PRO ALA PRO GLY THR PRO ALA PHE TRP VAL SEQRES 3 C 267 SER GLY TRP LEU GLY PRO GLN GLN TYR LEU SER TYR ASN SEQRES 4 C 267 SER LEU ARG GLY GLU ALA GLU PRO CYS GLY ALA TRP VAL SEQRES 5 C 267 TRP GLU ASN GLN VAL SER TRP TYR TRP GLU LYS GLU THR SEQRES 6 C 267 THR ASP LEU ARG ILE LYS GLU LYS LEU PHE LEU GLU ALA SEQRES 7 C 267 PHE LYS ALA LEU GLY GLY LYS GLY PRO TYR THR LEU GLN SEQRES 8 C 267 GLY LEU LEU GLY CYS GLU LEU GLY PRO ASP ASN THR SER SEQRES 9 C 267 VAL PRO THR ALA LYS PHE ALA LEU ASN GLY GLU GLU PHE SEQRES 10 C 267 MET ASN PHE ASP LEU LYS GLN GLY THR TRP GLY GLY ASP SEQRES 11 C 267 TRP PRO GLU ALA LEU ALA ILE SER GLN ARG TRP GLN GLN SEQRES 12 C 267 GLN ASP LYS ALA ALA ASN LYS GLU LEU THR PHE LEU LEU SEQRES 13 C 267 PHE SER CYS PRO HIS ARG LEU ARG GLU HIS LEU GLU ARG SEQRES 14 C 267 GLY ARG GLY ASN LEU GLU TRP LYS GLU PRO PRO SER MET SEQRES 15 C 267 ARG LEU LYS ALA ARG PRO SER SER PRO GLY PHE SER VAL SEQRES 16 C 267 LEU THR CYS SER ALA PHE SER PHE TYR PRO PRO GLU LEU SEQRES 17 C 267 GLN LEU ARG PHE LEU ARG ASN GLY LEU ALA ALA GLY THR SEQRES 18 C 267 GLY GLN GLY ASP PHE GLY PRO ASN SER ASP GLY SER PHE SEQRES 19 C 267 HIS ALA SER SER SER LEU THR VAL LYS SER GLY ASP GLU SEQRES 20 C 267 HIS HIS TYR CYS CYS ILE VAL GLN HIS ALA GLY LEU ALA SEQRES 21 C 267 GLN PRO LEU ARG VAL GLU LEU SEQRES 1 D 99 ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG HIS SEQRES 2 D 99 PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS TYR SEQRES 3 D 99 VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP LEU SEQRES 4 D 99 LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SER SEQRES 5 D 99 ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU LEU SEQRES 6 D 99 TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU TYR SEQRES 7 D 99 ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO LYS SEQRES 8 D 99 ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 E 267 ALA GLU SER HIS LEU SER LEU LEU TYR HIS LEU THR ALA SEQRES 2 E 267 VAL SER SER PRO ALA PRO GLY THR PRO ALA PHE TRP VAL SEQRES 3 E 267 SER GLY TRP LEU GLY PRO GLN GLN TYR LEU SER TYR ASN SEQRES 4 E 267 SER LEU ARG GLY GLU ALA GLU PRO CYS GLY ALA TRP VAL SEQRES 5 E 267 TRP GLU ASN GLN VAL SER TRP TYR TRP GLU LYS GLU THR SEQRES 6 E 267 THR ASP LEU ARG ILE LYS GLU LYS LEU PHE LEU GLU ALA SEQRES 7 E 267 PHE LYS ALA LEU GLY GLY LYS GLY PRO TYR THR LEU GLN SEQRES 8 E 267 GLY LEU LEU GLY CYS GLU LEU GLY PRO ASP ASN THR SER SEQRES 9 E 267 VAL PRO THR ALA LYS PHE ALA LEU ASN GLY GLU GLU PHE SEQRES 10 E 267 MET ASN PHE ASP LEU LYS GLN GLY THR TRP GLY GLY ASP SEQRES 11 E 267 TRP PRO GLU ALA LEU ALA ILE SER GLN ARG TRP GLN GLN SEQRES 12 E 267 GLN ASP LYS ALA ALA ASN LYS GLU LEU THR PHE LEU LEU SEQRES 13 E 267 PHE SER CYS PRO HIS ARG LEU ARG GLU HIS LEU GLU ARG SEQRES 14 E 267 GLY ARG GLY ASN LEU GLU TRP LYS GLU PRO PRO SER MET SEQRES 15 E 267 ARG LEU LYS ALA ARG PRO SER SER PRO GLY PHE SER VAL SEQRES 16 E 267 LEU THR CYS SER ALA PHE SER PHE TYR PRO PRO GLU LEU SEQRES 17 E 267 GLN LEU ARG PHE LEU ARG ASN GLY LEU ALA ALA GLY THR SEQRES 18 E 267 GLY GLN GLY ASP PHE GLY PRO ASN SER ASP GLY SER PHE SEQRES 19 E 267 HIS ALA SER SER SER LEU THR VAL LYS SER GLY ASP GLU SEQRES 20 E 267 HIS HIS TYR CYS CYS ILE VAL GLN HIS ALA GLY LEU ALA SEQRES 21 E 267 GLN PRO LEU ARG VAL GLU LEU SEQRES 1 F 99 ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG HIS SEQRES 2 F 99 PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS TYR SEQRES 3 F 99 VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP LEU SEQRES 4 F 99 LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SER SEQRES 5 F 99 ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU LEU SEQRES 6 F 99 TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU TYR SEQRES 7 F 99 ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO LYS SEQRES 8 F 99 ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 G 267 ALA GLU SER HIS LEU SER LEU LEU TYR HIS LEU THR ALA SEQRES 2 G 267 VAL SER SER PRO ALA PRO GLY THR PRO ALA PHE TRP VAL SEQRES 3 G 267 SER GLY TRP LEU GLY PRO GLN GLN TYR LEU SER TYR ASN SEQRES 4 G 267 SER LEU ARG GLY GLU ALA GLU PRO CYS GLY ALA TRP VAL SEQRES 5 G 267 TRP GLU ASN GLN VAL SER TRP TYR TRP GLU LYS GLU THR SEQRES 6 G 267 THR ASP LEU ARG ILE LYS GLU LYS LEU PHE LEU GLU ALA SEQRES 7 G 267 PHE LYS ALA LEU GLY GLY LYS GLY PRO TYR THR LEU GLN SEQRES 8 G 267 GLY LEU LEU GLY CYS GLU LEU GLY PRO ASP ASN THR SER SEQRES 9 G 267 VAL PRO THR ALA LYS PHE ALA LEU ASN GLY GLU GLU PHE SEQRES 10 G 267 MET ASN PHE ASP LEU LYS GLN GLY THR TRP GLY GLY ASP SEQRES 11 G 267 TRP PRO GLU ALA LEU ALA ILE SER GLN ARG TRP GLN GLN SEQRES 12 G 267 GLN ASP LYS ALA ALA ASN LYS GLU LEU THR PHE LEU LEU SEQRES 13 G 267 PHE SER CYS PRO HIS ARG LEU ARG GLU HIS LEU GLU ARG SEQRES 14 G 267 GLY ARG GLY ASN LEU GLU TRP LYS GLU PRO PRO SER MET SEQRES 15 G 267 ARG LEU LYS ALA ARG PRO SER SER PRO GLY PHE SER VAL SEQRES 16 G 267 LEU THR CYS SER ALA PHE SER PHE TYR PRO PRO GLU LEU SEQRES 17 G 267 GLN LEU ARG PHE LEU ARG ASN GLY LEU ALA ALA GLY THR SEQRES 18 G 267 GLY GLN GLY ASP PHE GLY PRO ASN SER ASP GLY SER PHE SEQRES 19 G 267 HIS ALA SER SER SER LEU THR VAL LYS SER GLY ASP GLU SEQRES 20 G 267 HIS HIS TYR CYS CYS ILE VAL GLN HIS ALA GLY LEU ALA SEQRES 21 G 267 GLN PRO LEU ARG VAL GLU LEU SEQRES 1 H 99 ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG HIS SEQRES 2 H 99 PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS TYR SEQRES 3 H 99 VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP LEU SEQRES 4 H 99 LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SER SEQRES 5 H 99 ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU LEU SEQRES 6 H 99 TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU TYR SEQRES 7 H 99 ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO LYS SEQRES 8 H 99 ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 I 15 ACE ARG PHE LE1 THR GLY HIS PHE GLY SAR MLE TYR PRO SEQRES 2 I 15 CYS NH2 SEQRES 1 J 15 ACE ARG PHE LE1 THR GLY HIS PHE GLY SAR MLE TYR PRO SEQRES 2 J 15 CYS NH2 SEQRES 1 K 15 ACE ARG PHE LE1 THR GLY HIS PHE GLY SAR MLE TYR PRO SEQRES 2 K 15 CYS NH2 SEQRES 1 L 15 ACE ARG PHE LE1 THR GLY HIS PHE GLY SAR MLE TYR PRO SEQRES 2 L 15 CYS NH2 MODRES 3M17 LE1 I 3 VAL 3-SULFANYL-L-VALINE MODRES 3M17 SAR I 9 GLY SARCOSINE MODRES 3M17 MLE I 10 LEU N-METHYLLEUCINE MODRES 3M17 LE1 J 3 VAL 3-SULFANYL-L-VALINE MODRES 3M17 SAR J 9 GLY SARCOSINE MODRES 3M17 MLE J 10 LEU N-METHYLLEUCINE MODRES 3M17 LE1 K 3 VAL 3-SULFANYL-L-VALINE MODRES 3M17 SAR K 9 GLY SARCOSINE MODRES 3M17 MLE K 10 LEU N-METHYLLEUCINE MODRES 3M17 LE1 L 3 VAL 3-SULFANYL-L-VALINE MODRES 3M17 SAR L 9 GLY SARCOSINE MODRES 3M17 MLE L 10 LEU N-METHYLLEUCINE HET ACE I 0 3 HET LE1 I 3 8 HET SAR I 9 5 HET MLE I 10 9 HET NH2 I 14 1 HET ACE J 0 3 HET LE1 J 3 8 HET SAR J 9 5 HET MLE J 10 9 HET NH2 J 14 1 HET ACE K 0 3 HET LE1 K 3 8 HET SAR K 9 5 HET MLE K 10 9 HET NH2 K 14 1 HET ACE L 0 3 HET LE1 L 3 8 HET SAR L 9 5 HET MLE L 10 9 HET NH2 L 14 1 HETNAM ACE ACETYL GROUP HETNAM LE1 3-SULFANYL-L-VALINE HETNAM SAR SARCOSINE HETNAM MLE N-METHYLLEUCINE HETNAM NH2 AMINO GROUP HETSYN LE1 L-LE1ICILLAMINE; L-PENICILLAMINE FORMUL 9 ACE 4(C2 H4 O) FORMUL 9 LE1 4(C5 H11 N O2 S) FORMUL 9 SAR 4(C3 H7 N O2) FORMUL 9 MLE 4(C7 H15 N O2) FORMUL 9 NH2 4(H2 N) FORMUL 13 HOH *183(H2 O) HELIX 1 1 GLY A 49 GLU A 54 5 6 HELIX 2 2 TRP A 59 PHE A 79 1 21 HELIX 3 3 LYS A 80 LEU A 82 5 3 HELIX 4 4 TRP A 131 GLN A 144 1 14 HELIX 5 5 LYS A 146 PHE A 157 1 12 HELIX 6 6 PHE A 157 GLY A 170 1 14 HELIX 7 7 GLY A 170 TRP A 176 1 7 HELIX 8 8 ASP A 246 HIS A 248 5 3 HELIX 9 9 GLY C 49 GLU C 54 5 6 HELIX 10 10 TRP C 59 PHE C 79 1 21 HELIX 11 11 LYS C 80 LEU C 82 5 3 HELIX 12 12 TRP C 131 GLN C 143 1 13 HELIX 13 13 LYS C 146 PHE C 157 1 12 HELIX 14 14 PHE C 157 GLY C 170 1 14 HELIX 15 15 GLY C 170 GLU C 175 1 6 HELIX 16 16 ASP C 246 HIS C 248 5 3 HELIX 17 17 GLY E 49 GLU E 54 5 6 HELIX 18 18 TRP E 59 PHE E 79 1 21 HELIX 19 19 LYS E 80 LEU E 82 5 3 HELIX 20 20 TRP E 131 GLN E 144 1 14 HELIX 21 21 LYS E 146 PHE E 157 1 12 HELIX 22 22 PHE E 157 GLY E 170 1 14 HELIX 23 23 GLY E 170 GLU E 175 1 6 HELIX 24 24 GLY G 49 GLU G 54 5 6 HELIX 25 25 TRP G 59 PHE G 79 1 21 HELIX 26 26 LYS G 80 LEU G 82 5 3 HELIX 27 27 TRP G 131 GLN G 144 1 14 HELIX 28 28 LYS G 146 PHE G 157 1 12 HELIX 29 29 PHE G 157 GLY G 170 1 14 HELIX 30 30 GLY G 170 GLU G 175 1 6 SHEET 1 A 8 GLU A 46 PRO A 47 0 SHEET 2 A 8 GLN A 33 ASN A 39 -1 N SER A 37 O GLU A 46 SHEET 3 A 8 PHE A 24 LEU A 30 -1 N LEU A 30 O GLN A 33 SHEET 4 A 8 LEU A 7 VAL A 14 -1 N HIS A 10 O SER A 27 SHEET 5 A 8 THR A 89 LEU A 98 -1 O LEU A 94 N TYR A 9 SHEET 6 A 8 SER A 104 LEU A 112 -1 O LYS A 109 N LEU A 93 SHEET 7 A 8 GLU A 115 ASP A 121 -1 O GLU A 115 N LEU A 112 SHEET 8 A 8 THR A 126 GLY A 128 -1 O THR A 126 N ASP A 121 SHEET 1 B 4 SER A 181 PRO A 188 0 SHEET 2 B 4 PHE A 193 PHE A 203 -1 O VAL A 195 N ARG A 187 SHEET 3 B 4 PHE A 234 LYS A 243 -1 O VAL A 242 N SER A 194 SHEET 4 B 4 ASP A 225 PRO A 228 -1 N GLY A 227 O HIS A 235 SHEET 1 C 4 LEU A 217 GLY A 220 0 SHEET 2 C 4 GLN A 209 ARG A 214 -1 N ARG A 214 O LEU A 217 SHEET 3 C 4 TYR A 250 GLN A 255 -1 O ILE A 253 N ARG A 211 SHEET 4 C 4 LEU A 263 VAL A 265 -1 O VAL A 265 N CYS A 252 SHEET 1 D 4 LYS B 6 SER B 11 0 SHEET 2 D 4 ASN B 21 PHE B 30 -1 O SER B 28 N LYS B 6 SHEET 3 D 4 PHE B 62 PHE B 70 -1 O PHE B 70 N ASN B 21 SHEET 4 D 4 GLU B 50 HIS B 51 -1 N GLU B 50 O TYR B 67 SHEET 1 E 4 LYS B 6 SER B 11 0 SHEET 2 E 4 ASN B 21 PHE B 30 -1 O SER B 28 N LYS B 6 SHEET 3 E 4 PHE B 62 PHE B 70 -1 O PHE B 70 N ASN B 21 SHEET 4 E 4 SER B 55 PHE B 56 -1 N SER B 55 O TYR B 63 SHEET 1 F 4 GLU B 44 ARG B 45 0 SHEET 2 F 4 GLU B 36 LYS B 41 -1 N LYS B 41 O GLU B 44 SHEET 3 F 4 TYR B 78 ASN B 83 -1 O ARG B 81 N ASP B 38 SHEET 4 F 4 LYS B 91 LYS B 94 -1 O VAL B 93 N CYS B 80 SHEET 1 G 8 GLU C 46 PRO C 47 0 SHEET 2 G 8 GLN C 33 ASN C 39 -1 N SER C 37 O GLU C 46 SHEET 3 G 8 PHE C 24 LEU C 30 -1 N VAL C 26 O TYR C 38 SHEET 4 G 8 SER C 6 VAL C 14 -1 N HIS C 10 O SER C 27 SHEET 5 G 8 THR C 89 LEU C 98 -1 O LEU C 94 N TYR C 9 SHEET 6 G 8 SER C 104 LEU C 112 -1 O LYS C 109 N LEU C 93 SHEET 7 G 8 GLU C 115 ASP C 121 -1 O MET C 118 N PHE C 110 SHEET 8 G 8 THR C 126 GLY C 128 -1 O THR C 126 N ASP C 121 SHEET 1 H 4 SER C 181 PRO C 188 0 SHEET 2 H 4 PHE C 193 PHE C 203 -1 O VAL C 195 N ARG C 187 SHEET 3 H 4 PHE C 234 LYS C 243 -1 O ALA C 236 N ALA C 200 SHEET 4 H 4 GLN C 223 PRO C 228 -1 N GLY C 227 O HIS C 235 SHEET 1 I 4 LEU C 217 ALA C 218 0 SHEET 2 I 4 GLN C 209 ARG C 214 -1 N ARG C 214 O LEU C 217 SHEET 3 I 4 TYR C 250 GLN C 255 -1 O ILE C 253 N ARG C 211 SHEET 4 I 4 LEU C 263 VAL C 265 -1 O VAL C 265 N CYS C 252 SHEET 1 J 4 LYS D 6 SER D 11 0 SHEET 2 J 4 ASN D 21 PHE D 30 -1 O ASN D 24 N TYR D 10 SHEET 3 J 4 PHE D 62 PHE D 70 -1 O LEU D 64 N VAL D 27 SHEET 4 J 4 GLU D 50 HIS D 51 -1 N GLU D 50 O TYR D 67 SHEET 1 K 4 LYS D 6 SER D 11 0 SHEET 2 K 4 ASN D 21 PHE D 30 -1 O ASN D 24 N TYR D 10 SHEET 3 K 4 PHE D 62 PHE D 70 -1 O LEU D 64 N VAL D 27 SHEET 4 K 4 SER D 55 PHE D 56 -1 N SER D 55 O TYR D 63 SHEET 1 L 4 GLU D 44 ARG D 45 0 SHEET 2 L 4 GLU D 36 LYS D 41 -1 N LYS D 41 O GLU D 44 SHEET 3 L 4 TYR D 78 ASN D 83 -1 O ASN D 83 N GLU D 36 SHEET 4 L 4 LYS D 91 LYS D 94 -1 O LYS D 91 N VAL D 82 SHEET 1 M 8 GLU E 46 PRO E 47 0 SHEET 2 M 8 GLN E 33 ASN E 39 -1 N SER E 37 O GLU E 46 SHEET 3 M 8 PHE E 24 LEU E 30 -1 N VAL E 26 O TYR E 38 SHEET 4 M 8 SER E 6 VAL E 14 -1 N HIS E 10 O SER E 27 SHEET 5 M 8 THR E 89 LEU E 98 -1 O LEU E 94 N TYR E 9 SHEET 6 M 8 SER E 104 LEU E 112 -1 O LYS E 109 N LEU E 93 SHEET 7 M 8 GLU E 115 ASP E 121 -1 O MET E 118 N PHE E 110 SHEET 8 M 8 THR E 126 GLY E 128 -1 O THR E 126 N ASP E 121 SHEET 1 N 4 SER E 181 PRO E 188 0 SHEET 2 N 4 PHE E 193 PHE E 203 -1 O VAL E 195 N ARG E 187 SHEET 3 N 4 PHE E 234 LYS E 243 -1 O ALA E 236 N ALA E 200 SHEET 4 N 4 GLN E 223 PRO E 228 -1 N GLN E 223 O SER E 239 SHEET 1 O 4 LEU E 217 ALA E 218 0 SHEET 2 O 4 GLN E 209 ARG E 214 -1 N ARG E 214 O LEU E 217 SHEET 3 O 4 TYR E 250 GLN E 255 -1 O CYS E 251 N LEU E 213 SHEET 4 O 4 LEU E 263 GLU E 266 -1 O VAL E 265 N CYS E 252 SHEET 1 P 4 LYS F 6 SER F 11 0 SHEET 2 P 4 ASN F 21 PHE F 30 -1 O SER F 28 N LYS F 6 SHEET 3 P 4 PHE F 62 PHE F 70 -1 O TYR F 66 N CYS F 25 SHEET 4 P 4 GLU F 50 HIS F 51 -1 N GLU F 50 O TYR F 67 SHEET 1 Q 4 LYS F 6 SER F 11 0 SHEET 2 Q 4 ASN F 21 PHE F 30 -1 O SER F 28 N LYS F 6 SHEET 3 Q 4 PHE F 62 PHE F 70 -1 O TYR F 66 N CYS F 25 SHEET 4 Q 4 SER F 55 PHE F 56 -1 N SER F 55 O TYR F 63 SHEET 1 R 4 GLU F 44 ARG F 45 0 SHEET 2 R 4 GLU F 36 LYS F 41 -1 N LYS F 41 O GLU F 44 SHEET 3 R 4 TYR F 78 HIS F 84 -1 O ARG F 81 N ASP F 38 SHEET 4 R 4 LEU F 87 LYS F 94 -1 O VAL F 93 N CYS F 80 SHEET 1 S 8 GLU G 46 PRO G 47 0 SHEET 2 S 8 GLN G 33 ASN G 39 -1 N SER G 37 O GLU G 46 SHEET 3 S 8 PHE G 24 LEU G 30 -1 N LEU G 30 O GLN G 33 SHEET 4 S 8 SER G 6 VAL G 14 -1 N HIS G 10 O SER G 27 SHEET 5 S 8 THR G 89 GLU G 97 -1 O LEU G 94 N TYR G 9 SHEET 6 S 8 THR G 107 LEU G 112 -1 O LYS G 109 N LEU G 93 SHEET 7 S 8 GLU G 115 ASP G 121 -1 O PHE G 117 N PHE G 110 SHEET 8 S 8 THR G 126 GLY G 128 -1 O THR G 126 N ASP G 121 SHEET 1 T 4 SER G 181 PRO G 188 0 SHEET 2 T 4 SER G 194 PHE G 203 -1 O VAL G 195 N ARG G 187 SHEET 3 T 4 PHE G 234 VAL G 242 -1 O VAL G 242 N SER G 194 SHEET 4 T 4 PHE G 226 PRO G 228 -1 N GLY G 227 O HIS G 235 SHEET 1 U 4 LEU G 217 GLY G 220 0 SHEET 2 U 4 GLN G 209 ARG G 214 -1 N ARG G 214 O LEU G 217 SHEET 3 U 4 TYR G 250 GLN G 255 -1 O ILE G 253 N ARG G 211 SHEET 4 U 4 LEU G 263 GLU G 266 -1 O VAL G 265 N CYS G 252 SHEET 1 V 4 LYS H 6 SER H 11 0 SHEET 2 V 4 ASN H 21 PHE H 30 -1 O SER H 28 N LYS H 6 SHEET 3 V 4 PHE H 62 PHE H 70 -1 O TYR H 66 N CYS H 25 SHEET 4 V 4 GLU H 50 HIS H 51 -1 N GLU H 50 O TYR H 67 SHEET 1 W 4 LYS H 6 SER H 11 0 SHEET 2 W 4 ASN H 21 PHE H 30 -1 O SER H 28 N LYS H 6 SHEET 3 W 4 PHE H 62 PHE H 70 -1 O TYR H 66 N CYS H 25 SHEET 4 W 4 SER H 55 PHE H 56 -1 N SER H 55 O TYR H 63 SHEET 1 X 4 GLU H 44 ARG H 45 0 SHEET 2 X 4 GLU H 36 LYS H 41 -1 N LYS H 41 O GLU H 44 SHEET 3 X 4 TYR H 78 ASN H 83 -1 O ARG H 81 N ASP H 38 SHEET 4 X 4 LYS H 91 LYS H 94 -1 O LYS H 91 N VAL H 82 SHEET 1 Y 2 PHE I 2 THR I 4 0 SHEET 2 Y 2 MLE I 10 PRO I 12 -1 O TYR I 11 N LE1 I 3 SHEET 1 Z 2 PHE J 2 THR J 4 0 SHEET 2 Z 2 MLE J 10 PRO J 12 -1 O TYR J 11 N LE1 J 3 SHEET 1 AA 2 PHE K 2 THR K 4 0 SHEET 2 AA 2 MLE K 10 PRO K 12 -1 O TYR K 11 N LE1 K 3 SHEET 1 AB 2 PHE L 2 THR L 4 0 SHEET 2 AB 2 MLE L 10 PRO L 12 -1 O TYR L 11 N LE1 L 3 SSBOND 1 CYS A 96 CYS A 159 1555 1555 2.05 SSBOND 2 CYS A 198 CYS A 252 1555 1555 2.02 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.03 SSBOND 4 CYS C 96 CYS C 159 1555 1555 2.04 SSBOND 5 CYS C 198 CYS C 252 1555 1555 2.04 SSBOND 6 CYS D 25 CYS D 80 1555 1555 2.02 SSBOND 7 CYS E 96 CYS E 159 1555 1555 2.04 SSBOND 8 CYS E 198 CYS E 252 1555 1555 2.03 SSBOND 9 CYS F 25 CYS F 80 1555 1555 2.04 SSBOND 10 CYS G 96 CYS G 159 1555 1555 2.04 SSBOND 11 CYS G 198 CYS G 252 1555 1555 2.03 SSBOND 12 CYS H 25 CYS H 80 1555 1555 2.03 SSBOND 13 LE1 I 3 CYS I 13 1555 1555 2.04 SSBOND 14 LE1 J 3 CYS J 13 1555 1555 2.04 SSBOND 15 LE1 K 3 CYS K 13 1555 1555 2.03 SSBOND 16 LE1 L 3 CYS L 13 1555 1555 2.04 LINK C ACE I 0 N ARG I 1 1555 1555 1.33 LINK C PHE I 2 N LE1 I 3 1555 1555 1.33 LINK C LE1 I 3 N THR I 4 1555 1555 1.33 LINK C GLY I 8 N SAR I 9 1555 1555 1.34 LINK C SAR I 9 N MLE I 10 1555 1555 1.34 LINK C MLE I 10 N TYR I 11 1555 1555 1.33 LINK C CYS I 13 N NH2 I 14 1555 1555 1.33 LINK C ACE J 0 N ARG J 1 1555 1555 1.33 LINK C PHE J 2 N LE1 J 3 1555 1555 1.33 LINK C LE1 J 3 N THR J 4 1555 1555 1.33 LINK C GLY J 8 N SAR J 9 1555 1555 1.34 LINK C SAR J 9 N MLE J 10 1555 1555 1.33 LINK C MLE J 10 N TYR J 11 1555 1555 1.33 LINK C CYS J 13 N NH2 J 14 1555 1555 1.32 LINK C ACE K 0 N ARG K 1 1555 1555 1.33 LINK C PHE K 2 N LE1 K 3 1555 1555 1.33 LINK C LE1 K 3 N THR K 4 1555 1555 1.33 LINK C GLY K 8 N SAR K 9 1555 1555 1.34 LINK C SAR K 9 N MLE K 10 1555 1555 1.34 LINK C MLE K 10 N TYR K 11 1555 1555 1.33 LINK C CYS K 13 N NH2 K 14 1555 1555 1.36 LINK C ACE L 0 N ARG L 1 1555 1555 1.33 LINK C PHE L 2 N LE1 L 3 1555 1555 1.33 LINK C LE1 L 3 N THR L 4 1555 1555 1.33 LINK C GLY L 8 N SAR L 9 1555 1555 1.34 LINK C SAR L 9 N MLE L 10 1555 1555 1.33 LINK C MLE L 10 N TYR L 11 1555 1555 1.33 LINK C CYS L 13 N NH2 L 14 1555 1555 1.36 CISPEP 1 GLY A 86 PRO A 87 0 -5.48 CISPEP 2 TYR A 204 PRO A 205 0 1.02 CISPEP 3 HIS B 31 PRO B 32 0 -1.86 CISPEP 4 GLY C 86 PRO C 87 0 -15.41 CISPEP 5 TYR C 204 PRO C 205 0 2.82 CISPEP 6 HIS D 31 PRO D 32 0 1.98 CISPEP 7 GLY E 86 PRO E 87 0 -14.74 CISPEP 8 TYR E 204 PRO E 205 0 1.95 CISPEP 9 HIS F 31 PRO F 32 0 5.96 CISPEP 10 GLY G 86 PRO G 87 0 -10.98 CISPEP 11 TYR G 204 PRO G 205 0 1.49 CISPEP 12 HIS H 31 PRO H 32 0 -1.22 CRYST1 114.320 118.300 248.330 90.00 90.00 90.00 C 2 2 21 32 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008747 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008453 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004027 0.00000